Nanoencapsulated dietary polyphenols for cancer prevention and treatment: successes and challenges

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. You W, Henneberg M. Cancer incidence increasing globally: the role of relaxed natural selection. Evol. Appl. 11(2), 140–152 (2017).
  MedlineGoogle Scholar
• 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: Cancer J. Clin. 68(1), 7–30 (2018).
  MedlineGoogle Scholar
• 3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer. J. Clin. 68(6), 394–424 (2018).
  MedlineGoogle Scholar
• 4. Cao Y, Teng J, Selbo J. Amorphous solid dispersion of epigallocatechin gallate for enhanced physical stability and controlled release. Pharmaceuticals 10(4), 88 (2017).
  Google Scholar
• 5. Siddiqui IA, Adhami VM, Bharali DJ et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 69(5), 1712–1716 (2009). • The encapsulation of epigallocatechin-3-gallate (EGCG) in poly(lactic acid)-poly(ethylene glycol) nanoparticles (NPs) showed tenfold dose advantage for exerting its proapoptotic and angiogenesis inhibitory effects in both in vitro and in vivo systems.
  Medline CASGoogle Scholar
• 6. Khan N, Bharali DJ, Adhami VM et al. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis 35(2), 415–423 (2014).
  Medline CASGoogle Scholar
• 7. Tabrez S, Priyadarshini M, Urooj M et al. Cancer chemoprevention by polyphenols and their potential application as nanomedicine. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Rev. 31(1), 67–98 (2013). • The different combination of nanopolyphenols has been suggested as cancer chemotherapeutic agents.
  Medline CASGoogle Scholar
• 8. Mashhadi Malekzadeh A, Ramazani A, Tabatabaei Rezaei SJ, Niknejad H. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy. J. Colloid. Interface. Sci. 490, 64–73 (2017).
  MedlineGoogle Scholar
• 9. Meybodi NM, Mortazavian AM, Monfared AB, Sohrabvandi S, Meybodi FA. Phytochemicals in cancer prevention: a review of the evidence. Iran. J. Cancer Prev. 10(1), e7219 (2017).
  Google Scholar
• 10. Nosrati N, Bakovic M, Paliyath G. Molecular mechanisms and pathways as targets for cancer prevention and progression with dietary compounds. Int. J. Mol. Sci. 18(10), e2050 (2017).
  MedlineGoogle Scholar
• 11. Mileo AM, Miccadei S. Polyphenols as modulator of oxidative stress in cancer disease: new therapeutic strategies. Oxid. Med. Cell. Longev. 2016, 6475624 (2016).
  MedlineGoogle Scholar
• 12. Abbas M, Saeed F, Anjum FM et al. Natural polyphenols: an overview. Int. J. Food. Prop. 20(8), 1689–1699 (2017).
  CASGoogle Scholar
• 13. Khan N, Mukhtar H. Tea polyphenols in promotion of human health. Nutrients 11(1), 39 (2019). • The role of tea polyphenols in the prevention of cancer, diabetes, cardiovascular and neurological diseases have been summarized in this article.
  Google Scholar
• 14. Rezaei SJT, Malekzadeh AM, Ramazani A, Niknejad H. pH-sensitive magnetite nanoparticles modified with hyperbranched polymers and folic acid for targeted imaging and therapy. Curr. Drug. Deliv. 16(9), 839–848 (2019).
  MedlineGoogle Scholar
• 15. Munin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds: a review. Pharmaceutics. 3(4), 793–829 (2011).
  Medline CASGoogle Scholar
• 16. Faraji L, Nadri H, Moradi A et al. Aminoalkyl-substituted flavonoids: synthesis, cholinesterase inhibition, β-amyloid aggregation, and neuroprotective study. Med. Chem. Res. 28(7), 974–983 (2019).
  CASGoogle Scholar
• 17. Hokmabad VR, Soodabeh D, Marziyeh A, Effat A, Roya S, Ali R. Effect of incorporating elaeagnus angustifolia extract in PCL-PEG-PCL nanofibers for bone tissue engineering. Front. Chem. Sci. Eng. 13(1), 108–119 (2019).
  Google Scholar
• 18. Oliveira LDLD, Carvalho MVD, Melo L. Health promoting and sensory properties of phenolic compounds in food. Rev. Ceres. 61, 764–779 (2014).
  Google Scholar
• 19. Hosseinzadeh Z, Ramazani A, Razzaghi-Asl N. Anti-cancer nitrogen-containing heterocyclic compounds. Curr. Org. Chem. 22(23), 2256–2279 (2018).
  CASGoogle Scholar
• 20. Hosseini F, Ramazani A, Mohammadi-Khanaposhtani M et al. Design, synthesis, and biological evaluation of novel 4-oxobenzo[d]1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents. Bioorg. Med. Chem. 27(13), 2914–2922 (2019).
  Medline CASGoogle Scholar
• 21. Hosseinzadeh Z, Ramazani A. An overview of the chemistry and pharmacological potentials of furanones skeletons. Curr. Org. Chem. 23(14), 1581–1599 (2019).
  CASGoogle Scholar
• 22. Conte R, De Luca I, De Luise A, Petillo O, Calarco A, Peluso G. New therapeutic potentials of nanosized phytomedicine. J. Nanosci. Nanotechnol. 16, 8176–8187 (2016).
  CASGoogle Scholar
• 23. Jalili-Baleh L, Babaei E, Abdpour S et al. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease. Eur. J. Med. Chem. 152, 570–589 (2018).
  Medline CASGoogle Scholar
• 24. Granja A, Pinheiro M, Reis S. Epigallocatechin gallate nanodelivery systems for cancer therapy. Nutrients 8(5), 307 (2016).
  Google Scholar
• 25. Islam MT, Tabrez S, Jabir NR et al. An insight into the therapeutic potential of major coffee components. Curr. Drug. Metab. 19(6), 544–556 (2018).
  Medline CASGoogle Scholar
• 26. Jabir NR, Islam MT, Tabrez S et al. An insight towards anticancer potential of major coffee constituents. BioFactors 44(4), 315–326 (2018). • The anticancer potential of different coffee components have been summarized in this article.
  CASGoogle Scholar
• 27. Kang H, Rha SY, Oh KW, Nam CM. Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiol. Health. 32, e2010001 (2010).
  MedlineGoogle Scholar
• 28. De Pace RCC, Liu X, Sun M et al. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J. Liposome. Res. 23(3), 187–196 (2013).
  MedlineGoogle Scholar
• 29. Kwak TW, Park SB, Kim H-J, Jeong Y-IL, Kang DH. Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. Onco. Targets. Ther. 10, 137–144 (2016).
  MedlineGoogle Scholar
• 30. Granja A, Frias I, Neves AR, Pinheiro M, Reis S. Therapeutic potential of epigallocatechin gallate nanodelivery systems. Biomed. Res. Int. 2017, 5813793 (2017).
  MedlineGoogle Scholar
• 31. Sanna V, Singh CK, Jashari R et al. Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci. Rep. 7, 41573 (2017).
  Medline CASGoogle Scholar
• 32. Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr. Cancer. 62(7), 883–890 (2010). •• Provides a foundation for the use of nano-EGCG to enhance the bioavailability and its effectiveness. The perceived toxicity could also be minimized by nano-EGCG.
  Medline CASGoogle Scholar
• 33. Shutava TG, Balkundi SS, Vangala P et al. Layer by layer coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano 3(7), 1877–1885 (2009).
  Medline CASGoogle Scholar
• 34. Chen C-C, Hsieh D-S, Huang K-J et al. Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug. Des. Devel. Ther. 8, 459–474 (2014).
  Medline CASGoogle Scholar
• 35. Siddiqui IA, Bharali DJ, Nihal M et al. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine 10(8), 1619–1626 (2014). •• Excellent anti-proliferative and pro-apoptotic effects of (-)-EGCG encapsulated in chitosan nanoparticles (NPs) have been reported in both in vitro and in vivo model.
  Medline CASGoogle Scholar
• 36. Narayanan S, Mony U, Vijaykumar DK, Koyakutty M, Paul-Prasanth B, Menon D. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine 11(6), 1399–1406 (2015).
  Medline CASGoogle Scholar
• 37. Shafiei SS, Solati-Hashjin M, Samadikuchaksaraei A, Kalantarinejad R, Asadi-Eydivand M, Abu Osman NA. Epigallocatechin gallate/layered double hydroxide nanohybrids: preparation, characterization, and in vitro anti-tumor study. PLoS ONE 10(8), e0136530 (2015).
  MedlineGoogle Scholar
• 38. Li J, Wu S, Wu C et al. Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery. Nanoscale 8(16), 8600–8606 (2016).
  Medline CASGoogle Scholar
• 39. Zeng L, Yan J, Luo L, Ma M, Zhu H. Preparation and characterization of (−)-epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on human breast cancer MCF-7 cells. Sci. Rep. 7, 45521 (2017).
  Medline CASGoogle Scholar
• 40. Yuan X, He Y, Zhou G, Li X, Feng A, Zheng W. Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach. J. Photochem. Photobiol. 183, 147–153 (2018).
  Medline CASGoogle Scholar
• 41. Hajipour H, Hamishehkar H, Nazari Soltan Ahmad S, Barghi S, Maroufi NF, Taheri RA. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers. Artif. Cells. Nanomed. Biotechnol. 46(S1), 283–292 (2018).
  Medline CASGoogle Scholar
• 42. Velavan B, Divya T, Sureshkumar A, Sudhandiran G. Nano-chemotherapeutic efficacy of (–)-epigallocatechin 3-gallate mediating apoptosis in A549 cells: involvement of reactive oxygen species mediated Nrf2/Keap1signaling. Biochem. Biophys. Res. Commun. 503(3), 1723–1731 (2018).
  Medline CASGoogle Scholar
• 43. Li K, Xiao G, Richardson JJ et al. Targeted therapy against metastatic melanoma based on self-assembled metal-phenolic nanocomplexes comprised of green tea catechin. Adv. Sci. (Weinh.) 6(5), 1801688 (2019).
  MedlineGoogle Scholar
• 44. Wang C, Sang H, Wang Y et al. Foe to friend: supramolecular nanomedicines consisting of natural polyphenols and bortezomib. Nano Lett. 18(11), 7045–7051 (2018).
  Medline CASGoogle Scholar
• 45. Liang C, Guo B, Wu H et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nat. Med. 21(3), 288–294 (2015).
  MedlineGoogle Scholar
• 46. Dowdy SF. Overcoming cellular barriers for RNA therapeutics. Nat. Biotechnol. 35(3), 222–229 (2017).
  Medline CASGoogle Scholar
• 47. Shen W, Wang Q, Shen Y et al. Green tea catechin dramatically promotes RNAi mediated by low-molecular-weight polymers. ACS. Cent. Sci. 4(10), 1326–1333 (2018).
  Medline CASGoogle Scholar
• 48. Liu C, Shen W, Li B, Li T, Chang H, Cheng Y. Natural polyphenols augment cytosolic protein delivery by a functional polymer. Chem. Mater. 31(6), 1956–1965 (2019).
  CASGoogle Scholar
• 49. Cheng X, Li M, Wang H, Cheng Y. All-small-molecule dynamic covalent gels with antibacterial activity by boronate-tannic acid gelation. Chinese Chem. Lett. doi:10.1016/j.cclet.2019.07.013 (2019).
  Google Scholar
• 50. Li M, Wang H, Hu J et al. Smart hydrogels with antibacterial properties built from all natural building blocks. Chem. Mater. 31(18), 7678–7685 (2019).
  CASGoogle Scholar
• 51. Massi A, Bortolini O, Ragno D et al. Research progress in the modification of quercetin leading to anticancer agents. Molecules 22(8), e1270 (2017).
  MedlineGoogle Scholar
• 52. Amiri A, Ramazani A, Jahanshahi M, Moghadamnia AA. Synthesis and evaluating of nanoporous molecularly imprinted polymers for extraction of quercetin as a bioactive component of medicinal plants. Iran. J. Chem. Chem. Eng. 35(4), 11–19 (2016).
  CASGoogle Scholar
• 53. Hashemzaei M, Far AD, Yari A et al. Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol. Rep. 38(2), 819–828 (2017).
  Medline CASGoogle Scholar
• 54. Amiri A, Ramazani A, Jahanshahi M, Moghadamnia AA. Synthesis of a nanostructured molecularly imprinted acrylic acid-based network copolymer as a solid sorbentforthe quercetinextraction. J. Nanostruct. 4(3), 277–283 (2014).
  Google Scholar
• 55. Chuan L, Jia Z, Yu-Jiao Z et al. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin. J. Nat. Med. 13(9), 641–652 (2015).
  MedlineGoogle Scholar
• 56. Huo C, Wan SB, Lam WH et al. The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology 16(5), 248–252 (2008).
  Medline CASGoogle Scholar
• 57. Pool H, Mendoza S, Xiao H, McClements DJ. Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility. Food. Funct. 4(1), 162–174 (2013).
  Medline CASGoogle Scholar
• 58. Bishayee K, Khuda-Bukhsh AR, Huh S-O. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol. Cells 38(6), 518–527 (2015).
  Medline CASGoogle Scholar
• 59. Ren K-W, Li Y-H, Wu G et al. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int. J. Oncol. 50(4), 1299–1311 (2017).
  Medline CASGoogle Scholar
• 60. Penalva R, González-Navarro CJ, Gamazo C, Esparza I, Irache JM. Zein nanoparticles for oral delivery of quercetin: pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia. Nanomedicine 13(1), 103–110 (2017).
  Medline CASGoogle Scholar
• 61. Singh S, Kushwah V, Agrawal AK, Jain S. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy. Nanomedicine. 13(5), 521–537 (2018).
  CASGoogle Scholar
• 62. Nan W, Ding L, Chen H et al. Topical use of quercetin-loaded chitosan nanoparticles against ultraviolet B radiation. Front. Pharmacol. 9, e826 (2018).
  MedlineGoogle Scholar
• 63. Yilmaz M, Karanastasis AA, Chatziathanasiadou MV et al. Inclusion of quercetin in gold nanoparticles decorated with supramolecular hosts amplifies its tumor targeting properties. ACS. Appl. Bio. Mater. 2(7), 2715–2725 (2019).
  Medline CASGoogle Scholar
• 64. Barbosa AI, Costa Lima SA, Reis S. Application of pH-responsive fucoidan/chitosan nanoparticles to improve oral quercetin delivery. Molecules 24(2), 346 (2019).
  Google Scholar
• 65. Srisa-Nga K, Mankhetkorn S, Okonogi S, Khonkarn R. Delivery of superparamagnetic polymeric micelles loaded with quercetin to hepatocellular carcinoma cells. J. Pharm. Sci. 108(2), 996–1006 (2019).
  Medline CASGoogle Scholar
• 66. Gholibegloo E, Mortezazadeh T, Salehian F et al. Folic acid decorated magnetic nanosponge: an efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging. J. Colloid. Interface. Sci. 556, 128–139 (2019).
  Medline CASGoogle Scholar
• 67. Gholibegloo E, Mortezazadeh T, Salehian F, Ramazani A, Amanlou M, Khoobi M. Improved curcumin loading, release, solubility and toxicity by tuning the molar ratio of cross-linker to β-cyclodextrin. Carbohydr. Polym. 213, 70–78 (2019).
  Medline CASGoogle Scholar
• 68. Hewlings SJ, Kalman DS. Curcumin: a review of its' effects on human health. Foods 6(10), e92 (2017).
  MedlineGoogle Scholar
• 69. Tomeh MA, Hadianamrei R, Zhao X. A review of curcumin and its derivatives as anticancer agents. Int. J. Mol. Sci. 20(5), 1033 (2019).
  CASGoogle Scholar
• 70. Khalil NM, Nascimento TCFD, Casa DM et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats. Colloids. Surf. B Biointerfaces. 101, 353–360 (2013).
  Medline CASGoogle Scholar
• 71. Zhou S, Zhang S, Shen H et al. Curcumin inhibits cancer progression through regulating expression of microRNAs. Tumour. Biol. 39(2), doi:10.1177/1010428317691680 (2017).
  Google Scholar
• 72. Liu G, Xiang T, Wu Q-F, Wang W-X. Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19. Oncol. Lett. 12(6), 5156–5162 (2016).
  Medline CASGoogle Scholar
• 73. Zhang L, Yang G, Zhang R et al. Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells. Int. J. Oncol. 53(2), 515–526 (2018).
  Medline CASGoogle Scholar
• 74. Ghalandarlaki N, Alizadeh AM, Ashkani-Esfahani S. Nanotechnology-applied curcumin for different diseases therapy. Biomed. Res. Int. 2014, 394264 (2014).
  MedlineGoogle Scholar
• 75. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNVR. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37(3), 223–230 (2009).
  Medline CASGoogle Scholar
• 76. Tsai Y-M, Chien C-F, Lin L-C, Tsai T-H. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetration. Int. J. Pharm. 416(1), 331–338 (2011).
  Medline CASGoogle Scholar
• 77. Xie X, Tao Q, Zou Y et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J. Agric. Food. Chem. 59(17), 9280–9289 (2011).
  Medline CASGoogle Scholar
• 78. Yallapu MM, Ebeling MC, Khan S et al. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol. Cancer Ther. 12(8), 1471–1480 (2013).
  Medline CASGoogle Scholar
• 79. Udompornmongkol P, Chiang B-H. Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications. J. Biomater. Appl. 30(5), 537–546 (2015).
  Medline CASGoogle Scholar
• 80. Thadakapally R, Aafreen A, Aukunuru J, Habibuddin M, Jogala S. Preparation and characterization of PEG-albumin-curcumin nanoparticles intended to treat breast cancer. Ind. J. Pharm. Sci. 78(1), 65 (2016).
  Medline CASGoogle Scholar
• 81. Kalashnikova I, Mazar J, Neal CJ et al. Nanoparticle delivery of curcumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2/Bax in human neuroblastoma. Nanoscale 9(29), 10375–10387 (2017).
  Medline CASGoogle Scholar
• 82. Song W, Muthana M, Mukherjee J, Falconer RJ, Biggs CA, Zhao X. Magnetic-silk core–shell nanoparticles as potential carriers for targeted delivery of curcumin into human breast cancer cells. ACS Biomater. Sci. Eng. 3(6), 1027–1038 (2017).
  Medline CASGoogle Scholar
• 83. Samrot AV, Burman U, Philip SA, N S Chandrasekaran K. Synthesis of curcumin loaded polymeric nanoparticles from crab shell derived chitosan for drug delivery. Inform. Med. Unlocked. 10, 159–182 (2018).
  Google Scholar
• 84. Vijayakurup V, Thulasidasan AT, G MS et al. Chitosan encapsulation enhances the bioavailability and tissue retention of curcumin and improves its efficacy in preventing B[a]P-induced lung carcinogenesis. Cancer Prev. Res. 12(4), 225–236 (2019).
  Medline CASGoogle Scholar
• 85. Harini L, Srivastava S, Gnanakumar GP et al. An ingenious non-spherical mesoporous silica nanoparticle cargo with curcumin induces mitochondria-mediated apoptosis in breast cancer (MCF-7) cells. Oncotarget 10(11), 1193–1208 (2019).
  MedlineGoogle Scholar
• 86. Kim J-H, Park E-Y, Ha H-K et al. Resveratrol-loaded nanoparticles induce antioxidant activity against oxidative stress. Asian-Australas. J. Anim. Sci. 29(2), 288–298 (2016).
  Medline CASGoogle Scholar
• 87. Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin. Drug. Deliv. 11(8), 1285–1298 (2014).
  Medline CASGoogle Scholar
• 88. Santos AC, Pereira I, Magalhães M et al. Targeting cancer via resveratrol-loaded nanoparticles administration: focusing on in vivo evidence. AAPS J. 21(4), 57 (2019).
  MedlineGoogle Scholar
• 89. Ruivo J, Francisco C, Oliveira R et al. The main potentialities of resveratrol for drug delivery systems. Braz. J. Pharm. 51(3), 499–513 (2015).
  CASGoogle Scholar
• 90. Dai Z, Li Y, Quarles LD et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine 14(12), 806–814 (2007).
  Medline CASGoogle Scholar
• 91. Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJH. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr. Rev. 66(8), 445–454 (2008).
  MedlineGoogle Scholar
• 92. Johnson WD, Morrissey RL, Usborne AL et al. Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food. Chem. Toxicol. 49(12), 3319–3327 (2011).
  Medline CASGoogle Scholar
• 93. Neves AR, Lúcio M, Martins S, Lima JLC, Reis S. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomedicine 8, 177–187 (2013).
  MedlineGoogle Scholar
• 94. Siu FY, Ye S, Lin H, Li S. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. Int. J. Nanomedicine 13, 4133–4144 (2018).
  Medline CASGoogle Scholar
• 95. Peñalva R, Morales J, González-Navarro CJ et al. Increased oral bioavailability of resveratrol by its encapsulation in casein nanoparticles. Int. J. Mol. Sci. 19(9), 2816 (2018).
  Google Scholar
• 96. Breuss JM, Atanasov AG, Uhrin P. Resveratrol and its effects on the vascular system. Int. J. Mol. Sci. 20(7), 1523 (2019).
  CASGoogle Scholar
• 97. Davidov-Pardo G, Mcclements DJ. Nutraceutical delivery systems: resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food. Chem. 167, 205–212 (2015).
  Medline CASGoogle Scholar
• 98. Bernkop-Schnürch A. Nanocarrier systems for oral drug delivery: do we really need them? Eur. J. Pharm. Sci. 49(2), 272–277 (2013).
  Medline CASGoogle Scholar
• 99. Teskač K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390(1), 61–69 (2010).
  Medline CASGoogle Scholar
• 100. Karthikeyan S, Hoti SL, Prasad NR. Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small cell lung cancer cells. Biomed. Pharmacother. 70, 274–282 (2015).
  Medline CASGoogle Scholar
• 101. Sanna V, Siddiqui IA, Sechi M, Mukhtar H. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Mol. Pharm. 10(10), 3871–3881 (2013).
  Medline CASGoogle Scholar
• 102. Figueiró F, Bernardi A, Frozza RL et al. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J. Biomed. Nanotechnol. 9(3), 516–526 (2013).
  Medline CASGoogle Scholar
• 103. Jung K-H, Lee JH, Park JW et al. Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo. Int. J. Pharm. 478(1), 251–257 (2015).
  Medline CASGoogle Scholar
• 104. Guo L, Peng Y, Li Y et al. Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line. Oncol. Lett. 9(3), 1359–1363 (2015).
  MedlineGoogle Scholar
• 105. Wang W, Zhang L, Chen T et al. Anticancer effects of resveratrol-loaded solid lipid nanoparticles on human breast cancer cells. Molecules. 22(11), 1814 (2017).
  Google Scholar
• 106. Nassir AM, Shahzad N, Ibrahim IaA, Ahmad I, Md S, Ain MR. Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells. Saudi. Pharm. J. 26(6), 876–885 (2018).
  MedlineGoogle Scholar
• 107. Zhang D, Zhang J, Zeng J et al. Nano-gold loaded with resveratrol enhance the anti-hepatoma effect of resveratrol in vitro and in vivo. J. Biomed. Nanotechnol. 15(2), 288–300 (2019). •• The increase in antihepatoma potential by nanogold loaded resveratrol has been reported in vitro and in vivo systems.
  Medline CASGoogle Scholar
• 108. Niedzwiecki A, Roomi MW, Kalinovsky T, Rath M. Anticancer efficacy of polyphenols and their combinations. Nutrients 8(9), 552 (2016).
  Google Scholar
• 109. Singh CK, Siddiqui IA, El-Abd S, Mukhtar H, Ahmad N. Combination chemoprevention with grape antioxidants. Mol. Nutr. Food Res. 60(6), 1406–1415 (2016).
  Medline CASGoogle Scholar
• 110. Singh CK, George J, Ahmad N. Resveratrol-based combinatorial strategies for cancer management. Ann. N.Y. Acad. Sci. 1290(1), 113–121 (2013).
  Medline CASGoogle Scholar
• 111. Sun X-D, Liu X-E, Huang D-S. Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Mol. Med. Rep. 6(6), 1267–1270 (2012).
  Medline CASGoogle Scholar
• 112. Du Q, Hu B, An H-M et al. Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol. Rep. 29(5), 1851–1858 (2013).
  Medline CASGoogle Scholar
• 113. Shindikar A, Singh A, Nobre M, Kirolikar S. Curcumin and resveratrol as promising natural remedies with nanomedicine approach for the effective treatment of triple negative breast cancer. J. Oncol. 2016, e9750785 (2016).
  MedlineGoogle Scholar
• 114. Masuelli L, Stefano ED, Fantini M et al. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas. Oncotarget 5(21), 10745–10762 (2014).
  MedlineGoogle Scholar
• 115. Sanna V, Pala N, Dessì G et al. Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. Int. J. Nanomedicine 9, 4935–4951 (2014). •• The green synthesis and characterization of gold-conjugated polyphenol NPs highlighting better antioxidant and biological activities have been reported.
  MedlineGoogle Scholar